
About Lifevision India
Lifevision India is a company based in Chandigarh (India) founded in 2010. It operates as a B2B. The company has 4 employees. Lifevision India operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Chandigarh, India
- Employees 4
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website lifevisionindia.com
- Social LinkedIn X Facebook
- Legal Name E-Vision India Private Limited
- Date of Incorporation 03 Aug, 2012
- Jurisdiction Faridabad, Haryana, India
- Annual Revenue₹4.44 Cr
FY 2025 · -12% YoY
- Net Profit₹8.2 Lakh
FY 2025 · 2% margin
- EBITDA₹20.8 Lakh
FY 2025 · 5% margin
- Employee Count4
Associated legal entities of Lifevision India
Lifevision India operates through E-Vision India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| E-Vision India Private Limited CIN U72200HR2012PTC046662 | Active | 03 Aug 2012 | Faridabad, Haryana | ₹4.4 Cr | 4 | 2 | View details |
Board of directors of E-Vision India Private Limited (Lifevision India)
E-Vision India Private Limited is the primary company behind Lifevision India. The board of E-Vision India Private Limited currently have 2 directors; the longest-serving is Shweta Shandilya, appointed in 2012.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shweta Shandilya DIN 03034806 | Director | 03 Aug 2012 | 14 yrs 2 mo | E-Vision India Private Limited |
| Vijay Shandilya DIN 03034945 | Director | 03 Aug 2012 | 14 yrs 2 mo | E-Vision India Private Limited |
Financials of Lifevision India
Figures of E-Vision India Private Limited, the primary company behind Lifevision India, for FY 2025. Revenue was ₹4.44 Cr (-12% year on year). Net profit was ₹8.2 Lakh (2% margin). EBITDA was ₹20.8 Lakh (5% margin). Revenue has grown at a compounded annual rate of +83% over three years and +39% over five years.
- ₹4.44 CrRevenue · FY 2025 · -12% YoY
- ₹8.2 LakhNet profit · 2% margin
- ₹20.8 LakhEBITDA · 5% margin
- ₹1 LakhPaid-up capital
- 4Employees (provident fund records)
- +83%Revenue CAGR, 3 years
- +39%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of E-Vision India Private Limited are on its company page.
Detailed financial statements for Lifevision India
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Lifevision India
Lifevision India operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| medpharm.com | 1998 | Guildford, United Kingdom | – | 108 | Topical and inhaled drug delivery formulations are developed and manufactured. |
Detailed competitors of Lifevision India
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Lifevision India
The website of Lifevision India (lifevisionindia.com) receives about 2.7K visits a month.
- Monthly visits2.7K
▲ 17.9% vs previous month
Similar companies to Lifevision India
10 companies that operate in the same segment as Lifevision India (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lifevision India
Lifevision India was founded in 2010.
Lifevision India is headquartered in Chandigarh, India.
Lifevision India has 4 employees.
The primary company behind Lifevision India, E-Vision India Private Limited, reported revenue of βΉ4.44 Cr for FY 2025, down 12% year on year.
Lifevision India, established in 2010, excels in providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and third-party services. A pharmaceutical company offering third-party manufacturing for products like syrups, creams, and ointments. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Lifevision India's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Lifevision India operates through E-Vision India Private Limited.
The legal entities of Lifevision India currently have 2 directors, including Shweta Shandilya, Vijay Shandilya.